These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 7681371)

  • 1. Interferon-alpha in malignant and viral diseases. A review.
    Dorr RT
    Drugs; 1993 Feb; 45(2):177-211. PubMed ID: 7681371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of interferon-alpha in virus infections.
    Finter NB; Chapman S; Dowd P; Johnston JM; Manna V; Sarantis N; Sheron N; Scott G; Phua S; Tatum PB
    Drugs; 1991 Nov; 42(5):749-65. PubMed ID: 1723372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological basis for the clinical use of interferon.
    Dianzani F
    Gut; 1993; 34(2 Suppl):S74-6. PubMed ID: 7686123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2a.
    Williams CD; Linch DC
    Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
    McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha interferons--new therapeutic modalities].
    Bajcetić M; Zigon N; Samardzić R; Beleslin DB
    Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
    Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
    Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
    Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
    J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of interferon therapy].
    Dittrich C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy: the interferon-alpha experience.
    Kirkwood J
    Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.
    Haria M; Benfield P
    Drugs; 1995 Nov; 50(5):873-96. PubMed ID: 8586031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-alpha, beta, gamma].
    Imanishi J
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2853-8. PubMed ID: 7993128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon therapy of chronic hepatitis B.
    Brunetto MR; Bonino F
    Intervirology; 2014; 57(3-4):163-70. PubMed ID: 25034484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
    Stuart-Harris RC; Lauchlan R; Day R
    Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.